
India’s leading private hospital chains are increasingly witnessing a decline in revenue contribution from government-backed health schemes, signaling a possible shift in strategy across the sector. Hospitals such as Max Healthcare, Fortis Healthcare, Narayana Health, and HealthCare Global are reportedly reassessing their participation amid growing financial strain from delayed payments and low reimbursement rates.
State-supported programmes like the Central Government Health Scheme (CGHS) and Ex-Servicemen Contributory Health Scheme (ECHS) typically contribute nearly 25% of revenues for top private hospitals, according to Praxis Global Alliance. However, this share is expected to decline by 3–5% by Q1 FY27 due to selective de-empanelment and capped bed allocations.
These schemes provide healthcare access to government employees, pensioners, and defence personnel at fixed rates, but hospitals argue that pricing constraints and delayed settlements are impacting profitability.
Industry players have highlighted mounting challenges in continuing participation. Max Healthcare has estimated a ₹200 crore revenue impact from CGHS participation, later narrowing the ongoing impact to ₹140 crore after adjustments. The hospital also discontinued certain services where margins fell below acceptable levels.
Similarly, Narayana Health has capped scheme volumes in its northern operations, citing delayed payments and drug reimbursement restrictions. HealthCare Global has also reported disruptions due to state scheme transitions and payment-related disputes, particularly impacting oncology services with long treatment cycles.
Hospitals are now prioritising payers with faster settlement cycles, including insurance and cash-paying patients, to maintain liquidity and working capital efficiency.
Healthcare chains are increasingly shifting focus toward high-value treatments and private patient segments to improve margins. Some hospitals are also pledging government receivables to non-banking financial companies (NBFCs) to manage short-term cash flow needs.
Fortis Healthcare has seen partial improvement after CGHS rate revisions, but concerns persist around ECHS pricing clarity and reimbursement delays.
The declining contribution of government health schemes marks a significant structural shift for India’s private hospital sector. While participation has not been formally reduced, rising financial pressure is prompting hospitals to recalibrate their payer mix, potentially reshaping access and affordability in the long term.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Published on: May 7, 2026, 12:53 PM IST

We're Live on WhatsApp! Join our channel for market insights & updates
